Cargando…

An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat

This article reviews an emerging therapeutic agent, which is currently in phase III development for the treatment of anemia secondary to chronic kidney disease, covering promising phase II results, drug characteristics, and the current phase III trials, which, if approved, may significantly impact t...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker, Kimberly A., Jones, John J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778168/
https://www.ncbi.nlm.nih.gov/pubmed/29285707
http://dx.doi.org/10.1007/s12325-017-0655-z
_version_ 1783294307844751360
author Becker, Kimberly A.
Jones, John J.
author_facet Becker, Kimberly A.
Jones, John J.
author_sort Becker, Kimberly A.
collection PubMed
description This article reviews an emerging therapeutic agent, which is currently in phase III development for the treatment of anemia secondary to chronic kidney disease, covering promising phase II results, drug characteristics, and the current phase III trials, which, if approved, may significantly impact the management of anemia in this patient population.
format Online
Article
Text
id pubmed-5778168
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-57781682018-02-01 An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat Becker, Kimberly A. Jones, John J. Adv Ther Review This article reviews an emerging therapeutic agent, which is currently in phase III development for the treatment of anemia secondary to chronic kidney disease, covering promising phase II results, drug characteristics, and the current phase III trials, which, if approved, may significantly impact the management of anemia in this patient population. Springer Healthcare 2017-12-28 2018 /pmc/articles/PMC5778168/ /pubmed/29285707 http://dx.doi.org/10.1007/s12325-017-0655-z Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any non-commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Becker, Kimberly A.
Jones, John J.
An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat
title An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat
title_full An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat
title_fullStr An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat
title_full_unstemmed An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat
title_short An Emerging Treatment Alternative for Anemia in Chronic Kidney Disease Patients: A Review of Daprodustat
title_sort emerging treatment alternative for anemia in chronic kidney disease patients: a review of daprodustat
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778168/
https://www.ncbi.nlm.nih.gov/pubmed/29285707
http://dx.doi.org/10.1007/s12325-017-0655-z
work_keys_str_mv AT beckerkimberlya anemergingtreatmentalternativeforanemiainchronickidneydiseasepatientsareviewofdaprodustat
AT jonesjohnj anemergingtreatmentalternativeforanemiainchronickidneydiseasepatientsareviewofdaprodustat
AT beckerkimberlya emergingtreatmentalternativeforanemiainchronickidneydiseasepatientsareviewofdaprodustat
AT jonesjohnj emergingtreatmentalternativeforanemiainchronickidneydiseasepatientsareviewofdaprodustat